WASHINGTON — The U.S. Food and Drug Administration yesterday held a hearing to weigh the possibility of introducing a new class of drugs that would be sold from behind the counter. These medications would require consultation with pharmacists rather than doctors, similar to the way the emergency contraceptive Plan B is sold now. Representing retail pharmacy at the hearing was Steve Giroux, president of the National Community Pharmacists Association, Alexandria, Va., which recently found that ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.